Article Details

Adagio Therapeutics (NASDAQ:ADGI) Stock Rating Upgraded by Morgan Stanley - ETF Daily News

Retrieved on: 2021-12-03 08:29:59

Tags for this article:

Click the tags to see associated articles and topics

Adagio Therapeutics (NASDAQ:ADGI) Stock Rating Upgraded by Morgan Stanley - ETF Daily News. View article details on hiswai:

Excerpt

Two Sigma Investments LP bought a new position in Adagio Therapeutics during the third quarter valued at approximately $1,002,000.

Article found on: etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up